Shyam Patel

Director Business Development at California Institute for Regenerative Medicine

Shyam Patel currently serves as Director for Business Development at CIRM. CIRM has deployed $2.7 billion to fund over 1000 cell, gene and regenerative medicine therapy development programs (140+ currently active) including 60 clinical trials. At CIRM, Shyam leads CIRM’s Business Development activities and manages the Industry Alliance Program (IAP). The IAP is a collaborative effort between CIRM and select industry partners to support development and commercialization of CIRM’s most promising portfolio projects. Prior to joining CIRM, Shyam led preclinical development of tissue-engineered graft implants as the CEO/CSO of NanoNerve, Inc. He also served as part-time Bioengineering faculty at UC Berkeley. Shyam holds a Ph.D. in Bioengineering from the Universities of California, Berkeley & San Francisco.